Page 131 - ESHRE2019
P. 131
Patient 1: No unexpected proliferation, no graft rejection after 1 year
Postoperative best corrected visual acuity did not improve but was maintained Her score on the National Eye Institute Visual Functioning Questionnaire
(VFQ)-25 increased from 48.8 (before surgery) to 58.3 (1 year after surgery).
Patient 2: Three aberrations in DNA copy number (deletions) were detected. No transplantation
PCC Stem Cells - ESHRE Vienna 2019
Clinical trials with hiPSC derivatives Parkinson disease/macular degeneration Autologous vs allogeneic
PCC Stem Cells - ESHRE Vienna 2019
126
PRECONGRESS COURSE 13 I VIENNA, AUSTRIA – 23 JUNE 2019 129
